Nicolas Fissolo

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Refining Treatment Monitoring in Patients With Relapsing Multiple Sclerosis Based on Changes on Neurofilament Light Chain Z-Scores.

Refining Treatment Monitoring in Patients With Relapsing Multiple Sclerosis Based on Changes on Neurofilament Light Chain Z-Scores.

Journal: Neurology

Published: August 20, 2026

Impact of preanalytical factors on blood CHI3L1 levels.

Impact of preanalytical factors on blood CHI3L1 levels.

Journal: Frontiers in immunology

Published: October 08, 2025

Cladribine Preserves Normal Central Nervous System Cellular Activity and Promotes Neuroprotection to Oxidative Stress Damage.

Cladribine Preserves Normal Central Nervous System Cellular Activity and Promotes Neuroprotection to Oxidative Stress Damage.

Journal: International journal of molecular sciences

Published: September 19, 2025

Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis.

Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis.

Journal: European journal of neurology

Published: August 31, 2025

Reduced CD40 expression in B cell subsets of individuals with radiologically isolated syndrome.

Reduced CD40 expression in B cell subsets of individuals with radiologically isolated syndrome.

Journal: Frontiers in immunology

Published: August 05, 2025

Cerebrospinal 14-3-3 Protein Levels as a Neuroaxonal Biomarker in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder.

Cerebrospinal 14-3-3 Protein Levels as a Neuroaxonal Biomarker in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 30, 2025

Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome.

Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome.

Journal: JAMA neurology

Published: June 02, 2025

Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy.

Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy.

Journal: European journal of neurology

Published: February 18, 2025

Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis.

Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: January 29, 2025

Usefulness of serum neurofilament light chain in chronic inflammatory demyelinating polyradiculoneuropathy.

Usefulness of serum neurofilament light chain in chronic inflammatory demyelinating polyradiculoneuropathy.

Journal: Journal of the neurological sciences

Published: October 23, 2024

Assessment of neuronal and glial serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease: the MULTIMOGAD study.

Assessment of neuronal and glial serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease: the MULTIMOGAD study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: September 26, 2024

Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis.

Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis.

Journal: Journal of neurology

Published: September 09, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026